90/014,448VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION10,464,992Closed

Status

Reexamination Certificate Issued

Filed

Feb 11, 2020

Last Updated

Jan 6, 2025

Art Unit

3991

Requester

Unknown

Requester Law Firm

Maier & Maier, PLLC

Requested By

Third Party

Patent OwnerInferred

Regeneron Pharmaceuticals Inc.

P.O. Law Firm

A&P

Sector (CPC)

CChemistry & Materials
C07Organic Chemistry
C07KPeptides

USPC

424Drug, Bio-Affecting And Body Treating Compositions

Reexam History (58 events)

Jan 6, 2025REEXInput Issue Number and Issue Date for Reexamination
Dec 30, 2024RXPTDIReexam Petition Decision - Dismissed
Dec 30, 2024MRTDIRX - Mail Petition Decision - Dismissed
Dec 12, 2024RXPUBSReexam Forwarded to Office of Publications
Dec 6, 2024MRNRCRX - Mail Notice of Intent to Issue a Reexam Certificate
Nov 27, 2024RXLET.Miscellaneous Incoming Letter
Oct 29, 2024RXRLFReExam Litigation Found
Oct 29, 2024RXLITSRReexam Litigation Search Conducted
Aug 6, 2024MRDCLRX - Mail Decision Lifting the Stay of Reexam Proceedings
Jan 19, 2024RXC/SRCertificate of Service
Jan 19, 2024RCCPRX - Concurrent Proceedings Notice
Sep 11, 2023RXRLFReExam Litigation Found
Sep 11, 2023RXLITSRReexam Litigation Search Conducted
Sep 8, 2023MRDTYRX - Mail Decision Staying Reexam Proceedings
Sep 1, 2023IDSCInformation Disclosure Statement considered
Aug 24, 2023RXPTDIReexam Petition Decision - Dismissed
Aug 24, 2023MRTDIRX - Mail Petition Decision - Dismissed
Mar 13, 2023WIDSInformation Disclosure Statement (IDS) Filed
Mar 13, 2023RXIDS.Information Disclosure Statement Filed
Mar 13, 2023RXC/SRCertificate of Service
Mar 13, 2023RCCPRX - Concurrent Proceedings Notice
Nov 24, 2021RXPET.Receipt of Petition in a Reexam
Nov 24, 2021RXC/SRCertificate of Service
Nov 19, 2021IDSCInformation Disclosure Statement considered
Oct 1, 2021RXPTDIReexam Petition Decision - Dismissed
Sep 30, 2021MRTDIRX - Mail Petition Decision - Dismissed
Feb 26, 2021WIDSInformation Disclosure Statement (IDS) Filed
Feb 26, 2021RXIDS.Information Disclosure Statement Filed
Feb 26, 2021RXC/SRCertificate of Service
Feb 26, 2021RCCPRX - Concurrent Proceedings Notice
Sep 10, 2020RXTTLRPTTitle Report
Sep 7, 2020RXFWDXDate Forwarded to Examiner
Jun 12, 2020RXOPPPETReexam - Opposition filed in response to petition
Jun 12, 2020RXC/SRCertificate of Service
May 29, 2020RXPET.Receipt of Petition in a Reexam
May 29, 2020RXPET.Receipt of Petition in a Reexam
May 29, 2020RXC/SRCertificate of Service
May 22, 2020PA..Change in Power of Attorney (May Include Associate POA)
May 21, 2020C.ADCorrespondence Address Change
May 20, 2020RXC/SRCertificate of Service
Apr 1, 2020MREXORX - Mail Ex Parte Request for Reexamination Granted
Mar 31, 2020NRX.Notice of Reexam Published in Official Gazette
Mar 8, 2020IDSCInformation Disclosure Statement considered
Mar 3, 2020RXLITSRReexam Litigation Search Conducted
Mar 2, 2020DOCKCase Docketed to Examiner in GAU
Feb 24, 2020MRPWPRX - Mail Pilot Waiver Program - Ex Parte Interview Summary
Feb 19, 2020MRXNReexamination Formalities Notice Mailed
Feb 19, 2020MRXNReexamination Formalities Notice Mailed
Feb 18, 2020RXPCOMCompletion of Preprocessing - Released to Assigned GAU
Feb 18, 2020RXNREQFDNotice of reexamination request filing date
Feb 18, 2020RXNREQAUNotice of assignment of reexamination request
Feb 18, 2020PRXRParalegal Reexam Review Complete
Feb 18, 2020FTFIFITF set to NO - revise initial setting
Feb 11, 2020WIDSInformation Disclosure Statement (IDS) Filed
Feb 11, 2020RXOSUB.RReexamination requested by third party requester
Feb 11, 2020RXOSUBReceipt of Original Ex Parte Reexam Request
Feb 11, 2020RXIDS.RReexam - Information Disclosure Statement Filed by Third Party Requester
Feb 11, 2020BIG.Entity Status Set To Undiscounted (Initial Default Setting or Status Change)

Prosecution, PTAB & CAFC

PTAB Proceedings (IPR, PGR, CBM, DER)

IPR2023-01312IPRTerminated-Adverse Judgment

Petitioner

Samsung Bioepis Co., Ltd.

Petition Filed

Aug 18, 2023

Institution

Dec 8, 2023

Decision

Feb 21, 2024

Terminated

Feb 21, 2024

IPR2023-00462IPRTerminated-Adverse Judgment

Petitioner

Celltrion, Inc. et al.

Petition Filed

Jan 17, 2023

Institution

Jul 20, 2023

Decision

Feb 21, 2024

Terminated

Feb 21, 2024

IPR2021-00402IPRTerminated

Petitioner

Chengdu Kanghong Biotechnology Co., Ltd. et al.

Petition Filed

Jan 7, 2021

Terminated

Jun 25, 2021

Federal Circuit (CAFC)

None found

Terminal Disclaimer

Filed — ApprovedJul 22, 2019

Prosecution History

DateCodeDescription
Jul 28, 2019P574PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED
Jul 22, 2019DISTTerminal Disclaimer Filed

Maintenance Fees

Grant
Nov 5, 2019
3.5-yr
May 5, 2023
Paid Apr 21, 2023
7.5-yr
May 5, 2027
11.5-yr
May 5, 2031
Expiry
Oct 12, 2038

Entity Status

Large Entity

Expires

Oct 12, 2038 (12.5 yr remaining)

Assignments

20082009201020112012201320142015201620172018FiledKELLY FRYEERIC FURFINEKENNETH S. GRAHAMDANIEL DIXREGENERON PHARMACEUTICALS, INC.
AssignmentReel/Frame: 047899/0360Recorded: Jan 4, 2019

From

DANIEL DIXInventor
Nov 26, 2007
KELLY FRYEInventor
Aug 17, 2007
ERIC FURFINEInventor
Aug 25, 2007
KENNETH S. GRAHAMInventor
Aug 30, 2007

To

REGENERON PHARMACEUTICALS, INC.